Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Allen C. Ho, MD, and Robert L. Avery, MD
Paola Dorta S., MD, MHA, and Andrés Kychenthal B., MD
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Recent Supplements
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
View Supplement
One to Watch: Samir N. Patel, MD
Editorially independent supported by Abbvie and Regenxbio
View Insert
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
One to Watch: Archana A. Nair, MD, MS
Complex Retinal Detachment Repair Facilitated by TissueBlue™
Supported by Zeiss
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE